AI-CVD vs DeepTek CXR Analyzer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by HeartLung AI
VS
by DeepTek

AI Verdict

AI-CVD and DeepTek CXR Analyzer are adjacent healthcare-AI tools, as they both leverage AI for medical imaging within the thoracic region to aid in diagnosis and screening. However, AI-CVD focuses on opportunistic quantitative analysis of cardiovascular and multisystem diseases using existing CT scans. In contrast, DeepTek CXR Analyzer provides computer-assisted detection for a broader range of pathologies on chest X-rays to enhance radiologist workflow.

Choose AI-CVD if…

Choose AI-CVD if your organization seeks to leverage existing CT scans for opportunistic, comprehensive cardiovascular and multisystem disease screening without additional imaging or radiation exposure. This tool is ideal for identifying hidden health risks through quantitative measurements like Coronary Artery Calcium (CAC) scoring, cardiac chamber volumetry, and epicardial fat analysis, enabling early detection from routine scans.

View AI-CVD →

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if your radiology department handles a high volume of chest X-rays and aims to significantly enhance workflow efficiency and diagnostic accuracy for common lung, pleural, and cardiac pathologies. This AI-powered CADe solution is best suited for assisting radiologists by automatically detecting and highlighting suspicious regions, thereby reducing workload and boosting productivity in X-ray interpretation.

View DeepTek CXR Analyzer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-CVD DeepTek CXR Analyzer
Pricing Unknown Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.
Deployment Unknown On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepTek CXR Analyzer

DeepTek CXR Analyzer provides more concrete metrics for workflow efficiency, claiming to reduce radiologist workload by 30-50% and boost productivity by 2x-3x. It also offers seamless DICOM-based PACS integration and compatibility with various X-ray modalities, directly addressing practical usability for radiologists.

Clinical Value

AI-CVD

AI-CVD offers a broader and more proactive clinical value by performing opportunistic screening for multiple cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. It provides a comprehensive set of measurements for conditions like coronary heart disease, heart failure, and osteoporosis.

Pricing & Value

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers a 'pay-per-use' pricing model, which provides greater transparency and flexibility for budgeting compared to AI-CVD's 'contact for pricing' approach. This model can offer better perceived value, especially for organizations with variable usage.

Enterprise Readiness

DeepTek CXR Analyzer

DeepTek CXR Analyzer explicitly states HIPAA compliance and BAA availability, and offers both cloud and on-premise deployment options. This provides greater flexibility and assurance for enterprise integration and data governance compared to AI-CVD's 'likely, contact vendor' for BAA and HIPAA.

Innovation

AI-CVD

AI-CVD's innovative approach lies in its comprehensive opportunistic screening capabilities, extracting a wide array of cardiovascular and multisystem health insights from existing CT scans without additional imaging. This maximizes the value of routine imaging for proactive early disease detection.

Support & Docs

DeepTek CXR Analyzer

DeepTek CXR Analyzer explicitly provides a dedicated customer support email and highlights a team of '140+ Experts delivering 24x7 services' for their AI-assisted reporting. This suggests a more comprehensive and readily available support system compared to AI-CVD, which provides general contact information and mentions a 'Knowledge Center'.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-CVD DeepTek CXR Analyzer
Name AI-CVD DeepTek CXR Analyzer
Company HeartLung Corporation DeepTek Medical Imaging Pvt
Primary Imaging Modality Existing CT scans (chest and abdominal) Chest X-rays
Core Function AI-powered quantitative imaging platform for opportunistic screening for cardiovascular and multisystem diseases AI-powered CADe solution for chest X-ray analysis, assisting radiologists by detecting and highlighting suspicious regions
Key Detections/Measurements Coronary Artery Calcium (CAC) scoring, Aortic wall/valve/mitral valve calcium analysis, Cardiac chamber volumetry, Epicardial fat volumetry, Aorta and pulmonary artery sizing Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs)

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and DeepTek CXR Analyzer.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-CVDu00ae from HeartLung Corporation performs opportunistic screening using existing chest and abdominal CT scans. DeepTek CXR Analyzer from DeepTek Medical Imaging Pvt is an AI-powered CADe solution specifically designed for chest X-ray analysis.
AI-CVDu00ae focuses on opportunistic screening for cardiovascular and multisystem diseases, enabling early detection of hidden health risks through quantitative imaging. DeepTek CXR Analyzer assists radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies on chest X-rays, aiming to improve workflow efficiency and diagnostic accuracy.
AI-CVDu00ae offers automated CT-derived measurements such as Coronary Artery Calcium (CAC) scoring, aortic/mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta/pulmonary artery sizing. DeepTek CXR Analyzer detects 28 findings covering lung, pleural, cardiac pathologies, and hardware, providing automatic identification, categorization, and highlighting of suspicious regions of interest.
AI-CVDu00ae is designed to use existing CT scans, claiming no additional imaging, radiation, contrast, or workflow disruption for opportunistic screening. DeepTek CXR Analyzer aims to reduce radiologist workload by 30-50% and boost productivity by 2x-3x through intelligent segregation of scans and seamless DICOM-based PACS integration.
For AI-CVDu00ae, pricing information requires direct contact with HeartLung Corporation. DeepTek CXR Analyzer operates on a pay-per-use model and is available as a technology offering or an AI-assisted reporting service.
AI Tool Finder
AI-powered search. Results may not be comprehensive.